sábado, 17 de mayo de 2025

The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position Even at discounted prices, branded medicines are still beyond reach for many

https://www.statnews.com/2025/04/29/compounded-glp-1-drugs-patients-seek-semaglutide-alternatives-wegovy-zepbound-mounjaro/?utm_campaign=breaking_news&utm_medium=email&_hsenc=p2ANqtz-8qmM96NmgH-AtT71wkEeEe6u-LYi1cNrJT2SMH-nhlpnuMtTSQvp1paS8aLeuzJpFpN8Jn4YEm161vYDJRJMzVx4ZOtw&_hsmi=361803897&utm_content=361803897&utm_source=hs_email

No hay comentarios: